The How: Current Predictors of Response to Immune Checkpoint Inhibitors

Download this slideset to review expert guidance on optimal biomarker testing in lung cancer, including molecular testing by NGS and PD-L1 testing to predict response to checkpoint inhibitor–based therapy.
Sanjay Mukhopadhyay, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 4.71 MB
Released: November 5, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AstraZeneca
Bristol-Myers Squibb
Genentech
Merck Sharp & Dohme Corp

Related Content

From Clinical Care Options (CCO), video featuring expert insights on best practices for nurses within a multidisciplinary CAR T-cell therapy care team

person default Caron A. Jacobson, MD
Program Director
Alix Beaupierre, BSN, RN, OCN person default Kathleen McDermott, RN, BSN, OCN, BMTCN
Registered Nurses: 2.0 Nursing contact hours Released: July 8, 2020 Expired: July 7, 2021

Gain key clinical insights fast, with this short slideset from CCO on the optimal use of immune checkpoint inhibitors for RCC

M. Dror Michaelson, MD, PhD Robert Motzer, MD Released: July 7, 2020

Gain key clinical insights fast, with this short slideset from CCO on treatment options for patients with urothelial cancer

Daniel P. Petrylak, MD
Program Director
Matthew I. Milowsky, MD Jonathan E. Rosenberg, MD
Released: July 7, 2020

Nivolumab plus ipilimumab, with or without chemotherapy, is now approved for advanced NSCLC. Read this expert commentary from CCO on how to best use these regimens in clinical practice.

Stephen V. Liu, MD Released: July 6, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?